Provided by Tiger Trade Technology Pte. Ltd.

PEIJIA-B

6.170
+0.0400.65%
Volume:503.00K
Turnover:3.10M
Market Cap:4.15B
PE:-18.23
High:6.250
Open:6.220
Low:6.080
Close:6.130
52wk High:9.360
52wk Low:3.720
Shares:672.00M
HK Float Shares:672.00M
Volume Ratio:0.98
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.338
ROE:-10.96%
ROA:-5.04%
PB:1.86
PE(LYR):-18.23
PS:5.49

Loading ...

MP CARDIOFLOW-B Shares Surge Over 6% as Implantable Defibrillator Enters Expedited Review Pathway

Stock News
·
Feb 16

MP CARDIOFLOW-B's Innovative Defibrillator Accepted into Expedited Regulatory Review Pathway

Stock News
·
Feb 13

BIOSINO BIO-TEC Subsidiary Secures Malaysian Medical Device Approval for Its BioCyte Flow Cytometers

Stock News
·
Feb 13

Heart Failure Device Maker BioVentrix Files for US IPO Seeking $17 Million

Stock News
·
Feb 13

AI Integration in Hospitals Brings Risks of Surgical Errors and Misidentified Organs

Deep News
·
Feb 11

Beihai City Conducts Pre-Spring Festival Medical Device Supervision

Deep News
·
Feb 09

Hainan Free Trade Port Achieves Full-Cycle Closure for Medical Equipment Bonded Maintenance

Deep News
·
Feb 09

Peijia Medical Files for EU Approval of Heart Implant

MT Newswires Live
·
Feb 09

Peijia Medical (9996) Submits EU MDR CE Mark Registration for GeminiOne® TEER System

Bulletin Express
·
Feb 09

PEIJIA-B Submits EU MDR Application for GeminiOne® TEER System

Stock News
·
Feb 09

Peijia Medical reicht EU MDR CE Mark Registrierung für GeminiOne TEER System ein

Reuters
·
Feb 09

Three-Tier Coordination Ensures Safety, Targeted Oversight Protects Public Health: Ningyang County Market Supervision Authority in Shandong Province Fully Safeguards Medical Device Security During Spring Festival

Deep News
·
Feb 06

Peijia Medical Anticipates Rise in 2025 Revenue

MT Newswires Live
·
Feb 06

BRIEF-Peijia Medical Posts Jan To Dec Unaudited Revenue Of RMB700 Million–RMB720 Million

Reuters
·
Feb 06

PEIJIA-B Reports 2025 Annual Results with Revenue of RMB 7-7.2 Billion, Up 13.7–17.0% Year-on-Year

Stock News
·
Feb 06

Peijia Medical (9996) Releases Unaudited 2025 Performance With Notable Growth in Neurointervention and TAVR

Bulletin Express
·
Feb 06

Peijia Medical - Jan to Dec Unaudited Revenue RMB700.0 Mln–RMB720.0 Mln

THOMSON REUTERS
·
Feb 06

Peijia Medical - Unaudited Result Due to Strong Performance Across All 3 Product Lines of Neurointerventional Business, Others in FY

THOMSON REUTERS
·
Feb 06

Peijia Medical Reports 2025 Revenue of RMB 700-720 Million

Reuters
·
Feb 06

Leading Medical Device Firm Backed by Sequoia Capital Goes Public

Deep News
·
Feb 05